Mike Kanan | Chief Financial Officer |
Greg Divis | Chief Executive Officer |
Jordan Dubow | Chief Medical Officer |
François Brisebois | Laidlaw |
Yinglu Zhang | Ladenburg Thalmann |
Michael Sesser | DWS |
Good morning, ladies and gentlemen. Thank you for standing by and welcome to the Avadel Pharmaceuticals Second Quarter 2019 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
I will now turn the call over to Mr. Mike Kanan, Chief Financial Officer of Avadel.